{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T22:19:18Z","timestamp":1649197158100},"reference-count":3,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.eururo.2011.03.050","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T12:02:06Z","timestamp":1302868926000},"page":"e1","source":"Crossref","is-referenced-by-count":1,"title":["Re: Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Gu\u00e9rin and with Bacillus Calmette-Gu\u00e9rin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993). Eur Urol 2011;59:438\u201346"],"prefix":"10.1016","volume":"60","author":[{"given":"Wei Ling","family":"Ooi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Stockler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dickon","family":"Hayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2011.03.050_bib0005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2010.11.038","volume":"59","author":"Oosterlinck","year":"2011","journal-title":"Eur Urol"},{"issue":"Suppl 3","key":"10.1016\/j.eururo.2011.03.050_bib0010","first-page":"150","article-title":"Intravesical chemotherapy plus BCG in non-muscle invasive bladder cancer\u2014a systematic review with meta-analysis [abstract 201]","volume":"6","author":"Houghton","year":"2010","journal-title":"Asia-Pac J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.03.050_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(05)70472-1","article-title":"Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial","volume":"7","author":"Di Stasi","year":"2006","journal-title":"Lancet Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283811003228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283811003228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T09:23:00Z","timestamp":1543828980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283811003228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":3,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0302283811003228"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2011.03.050","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}